140 related articles for article (PubMed ID: 12076326)
21. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
22. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
23. [Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma].
Li QL; Chen FJ; Zeng ZY; Yang AK; Wu QL; Zhang HZ; Hou JH
Ai Zheng; 2006 Feb; 25(2):235-40. PubMed ID: 16480594
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of cervical node status in head and neck squamous cell carcinoma.
Burusapat C; Jarungroongruangchai W; Charoenpitakchai M
World J Surg Oncol; 2015 Feb; 13():51. PubMed ID: 25889704
[TBL] [Abstract][Full Text] [Related]
25. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).
Ludwig HC; Ahkavan-Shigari R; Rausch S; Schallock K; Quentin C; Ziegler D; Bockermann V; Markakis E
Anticancer Res; 2000; 20(1A):305-10. PubMed ID: 10769672
[TBL] [Abstract][Full Text] [Related]
26. Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth.
Woolgar JA; Scott J
Head Neck; 1995; 17(6):463-72. PubMed ID: 8847204
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue.
Kurokawa H; Yamashita Y; Takeda S; Zhang M; Fukuyama H; Takahashi T
Head Neck; 2002 Aug; 24(8):731-6. PubMed ID: 12203797
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
29. Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer.
O-charoenrat P; Pillai G; Patel S; Fisher C; Archer D; Eccles S; Rhys-Evans P
Oral Oncol; 2003 Jun; 39(4):386-90. PubMed ID: 12676259
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and pathological related factors of occult cervical lymph node metastasis in squamous cell carcinoma of tongue].
Li QL; Chen FJ; Zeng ZY; Yang AK; Wu QL; Zhang HZ; Wu GH; Xu GP; Guo ZM; Zhang Q
Ai Zheng; 2003 Jan; 22(1):66-70. PubMed ID: 12561440
[TBL] [Abstract][Full Text] [Related]
31. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Kono T; Yazawa K; Igarashi J; Watanabe H; Nimura Y; Hanazaki K; Adachi W; Amano J
Hepatogastroenterology; 1999; 46(26):952-8. PubMed ID: 10370645
[TBL] [Abstract][Full Text] [Related]
32. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Int J Oncol; 2000 Dec; 17(6):1099-105. PubMed ID: 11078794
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
[TBL] [Abstract][Full Text] [Related]
34. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth.
Pimenta Amaral TM; Da Silva Freire AR; Carvalho AL; Pinto CA; Kowalski LP
Oral Oncol; 2004 Sep; 40(8):780-6. PubMed ID: 15288831
[TBL] [Abstract][Full Text] [Related]
36. A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma.
Matsushita Y; Yanamoto S; Takahashi H; Yamada S; Naruse T; Sakamoto Y; Ikeda H; Shiraishi T; Fujita S; Ikeda T; Asahina I; Umeda M
Int J Oral Maxillofac Surg; 2015 May; 44(5):543-8. PubMed ID: 25697063
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of vascular endothelial growth factor expression in patients with carcinoma of the mouth floor and tongue.
Broćić M; Kozomara R; Cerović S; Jović N; Vukelić-Marković S; Stosić S
Vojnosanit Pregl; 2009 Jun; 66(6):440-8. PubMed ID: 19583141
[TBL] [Abstract][Full Text] [Related]
38. Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth.
Dias FL; Lima RA; Kligerman J; Farias TP; Soares JR; Manfro G; Sa GM
Otolaryngol Head Neck Surg; 2006 Mar; 134(3):460-5. PubMed ID: 16500445
[TBL] [Abstract][Full Text] [Related]
39. Correlation between lymphatic vessel density and regional metastasis in squamous cell carcinoma of the tongue.
Chung MK; Min JY; So YK; Ko YH; Jeong HS; Son YI; Baek CH
Head Neck; 2010 Apr; 32(4):445-51. PubMed ID: 19672869
[TBL] [Abstract][Full Text] [Related]
40. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
